Gilead Sciences (GILD) Target Lifted at Needham & Company Post Q4

February 5, 2014 6:52 AM

Needham & Company analyst Alan Carr reiterated a Buy rating on Gilead Sciences (NASDAQ: GILD) and raised his price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found